View Clinical Trial (Medical Research Study)

A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-60031(Clinical Trial 298607)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Gurnee
State:  
IL
Zip Code: 60031
Conditions: Anemia - Chronic Kidney Disease
Purpose: This study will evaluate the efficacy and safety of intravenous MK2578, given as maintenance treatment for renal anemia in chronic kidney disease patients on dialysis who were previously receiving erythropoietin stimulating agents.
Study summary: This study consists of a 12-week base study (MK2578-003-00) and an optional 40-week extension study (MK2578-003-10). Patients who complete 12 weeks of treatment in the base study will enter the extension on the most recent dose administered in the base study or a newly adjusted dose, if adjustment is required to bring hemoglobin (Hb) levels within range. Patients' doses of MK2578 will be adjusted upward or downward during the extension study to maintain Hb in the range of 10-12 g/dL.
Criteria: Inclusion Criteria: - Base Study: - Patient is male or is a female who either cannot have children or who agrees to use appropriate contraceptive measures - Patient has been on hemodialysis for at least 6 months when informed consent is signed - patient has received intravenous epoetin alfa or epoetin beta for a least 6 months when the informed consent is signed - Extension Study: - Patient completed the base study through Week 12 - Patient tolerated MK2578 and demonstrated compliance with study procedures Exclusion Criteria: - Patient has a life expectancy of less than 6 months - Patient is scheduled for a kidney transplant within the next 6 months - Patient has had a blood transfusion within 12 weeks of screening - Patient has had major surgery within 12 weeks of screening or plans to have surgery - Patient has HIV - Patient has history of blood dyscrasia, hematologic disorders or any other disease known to cause anemia - Patient has severe congestive heart failure - Patient has a history of malignant cancer, except certain skin or cervical cancers - Patient has a history of grand mal seizures within the last 6 months
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: February 17, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.